BillionToOne Funding & Investors
BillionToOne, Inc. operates as a diagnostics company. The Company detects genetic disorders in the developing baby from maternal blood, as well as invents the patent-pending molecular counter platform, which increases the resolution of cell-free DNA detection by over a thousandfold. BillionToOne serves customers in the United States.
billiontoone.comTotal Amount Raised: $295,900,000
BillionToOne Funding Rounds
Seed
$2,400,000
Seed Investors
NewDo VentureWei GuoPacific 8 VenturesUpHonest CapitalFRIALEEndpoint VenturesLuigi BajettiSeries C
$125,000,000
Series C Investors
Adams Street PartnersHummingbird VenturesFifty YearsPacific 8 VenturesTIME BioVenturesNeotribe VenturesLibertus CapitalBaillie Gifford & CoNorwest Venture PartnersCivilization Ventures500 GlobalSeries B
$55,000,000
Series B Investors
Hummingbird VenturesY CombinatorNorwest Venture PartnersNeotribe VenturesLibertus CapitalFour Rivers Group500 GlobalFifty YearsSeries A
$15,000,000
Series A Investors
Hummingbird VenturesNeotribe VenturesHOF CapitalCivilization VenturesPacific 8 VenturesY Combinator500 IstanbulLibertus CapitalFRIALEAndrea Dusi500 GlobalFifty YearsAlmoayed VenturesAbenteuer VenturesSeries A
$15,000,000
Series A Investors
Hummingbird VenturesNeotribe VenturesY CombinatorCivilization VenturesHOF Capital500 GlobalFifty YearsDebt Financing
$35,000,000
Debt Financing Investors
Bridge BankSeries C
$48,500,000
Series C Investors
TIME BioVenturesNeotribe VenturesHummingbird VenturesFifty YearsNorwest Venture PartnersLibertus CapitalAdams Street PartnersBaillie Gifford & Co
Funding info provided by Diffbot.